Document Type

Article

Publication Date

4-26-2018

Publication Title

Journal of Medicinal Chemistry

ISSN

0022-2623

Volume

61

Issue/No.

8

First Page

3738

Last Page

3744

Abstract

β-Defensin 3 (BD3) was identified as a ligand for the melanocortin receptors (MCRs) in 2007, although the pharmacology activity of BD3 has not been clearly elucidated. Herein, it is demonstrated that human BD3 and mouse BD3 are full micromolar agonists at the MCRs. Furthermore, mouse β-defensin 1 (BD1) and human BD1 are also MCR micromolar agonists. This work identifies BD1 as an endogenous MCR ligand and clarifies the controversial role of BD3 as a micromolar agonist.

ORCID ID

0000-0002-6434-2151

DOI

10.1021/acs.jmedchem.8b00251

Peer Reviewed

Find in your library

Share

COinS